Sichuan Kelun Pharmaceutical Co., Ltd. Class A
002422
Rankning i aktier
#2008
Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and... Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally. The company operates through Chuanning, Botai, and Other Business segments. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion sets, sterile dispensing and injection syringes, vein detained needles, nebulizer sets, and vacuum blood collection tubes; over-the-counter products; and APIs to treat cardiovascular, IPF, ED, anti-tumor, anti-emetic, antibiotic, VB12, anti-rheumatoid arthritis, multiple sclerosis, anti-schizophrenia, CKD and anti-anemia, polypeptide, and other indications. It also provides ambroxol hydrochloride, potassium chloride, sodium chloride, magnesium sulfate, glucose, sterile water, sodium bicarbonate, lidocaine hydrochloride, vitamin B6, ribavirin, ceftazidime, 5% glucose, and ceftriaxone sodium injections. In addition, the company engages in investment; import and export; enterprise management; logistics and transportation; business services; agricultural non-staple food processing; production and sale of pharmaceutical intermediates; research and development of bio-based materials technology; Internet and related services; crop planting; professional technical; biotechnology extension; socio-economic consultation; technology promotion; medical research and testing exhibition; general cargo road transport; ecological protection and environmental management; and wholesale and retail. It exports its products to Japan. The company was formerly known as Sichuan Kelun Pharmaceutical Factory Co., Ltd and changed its name to Sichuan Kelun Pharmaceutical Co., Ltd. in August 2003. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. operates as a subsidiary of Sichuan Kelun Industry Group CO., LTD.
Aktiekurs
$6.40
Marknadsvärde
$10.19B
Förändring (1 dag)
-0.77%
Förändring (1 år)
27.14%
Land
CN
Handel Sichuan Kelun Pharmaceutical Co., Ltd. Class A (002422)
Kategori
Healthcare
Rörelsemarginal för Sichuan Kelun Pharmaceutical Co., Ltd. Class A (002422)
Rörelsemarginal per October 2026 TTM: 8.12%
Enligt de senaste finansiella rapporterna och aktiekursen för Sichuan Kelun Pharmaceutical Co., Ltd. Class A är företagets nuvarande rörelsemarginal (TTM) 8.12%. Vid slutet av 2024 var rörelsemarginalen 20.29%.
Historik för rörelsemarginal för Sichuan Kelun Pharmaceutical Co., Ltd. Class A från 2007 till 2026
Rörelsemarginal vid slutet av varje år
| År | Rörelsemarginal | Ändra |
|---|---|---|
| 2026 (TTM) | 8.12% | -25.98% |
| 2025 | 10.97% | -45.93% |
| 2024 | 20.29% | 19.14% |
| 2023 | 17.03% | 47.70% |
| 2022 | 11.53% | 50.92% |
| 2021 | 7.64% | 24.63% |
| 2020 | 6.13% | -15.33% |
| 2019 | 7.24% | -12.67% |
| 2018 | 8.29% | -18.08% |
| 2017 | 10.12% | 32.63% |
| 2016 | 7.63% | 3.25% |
| 2015 | 7.39% | -45.54% |
| 2014 | 13.57% | -19.27% |
| 2013 | 16.81% | -19.99% |
| 2012 | 21.01% | 1.99% |
| 2011 | 20.60% | 9.93% |
| 2010 | 18.74% | 20.36% |
| 2009 | 15.57% | 15.59% |
| 2008 | 13.47% | 10.86% |
| 2007 | 12.15% | 0.00% |
Rörelsemarginal för liknande företag eller konkurrenter
| Företag | Rörelsemarginal | Skillnad i rörelsemarginal | Land |
|---|---|---|---|
| 38.59% | -95.25% |
US
|
|
| -149.01% | -118.35% |
US
|
|
| 25.57% | -96.85% |
AU
|
|
| 31.23% | -96.15% |
BE
|
|
| 28.81% | -96.45% |
NL
|
Vad är ett företags Rörelsemarginal?
Rörelsemarginal är en viktig indikator för att bedöma ett företags lönsamhet. Högre Rörelsemarginals är generellt bättre eftersom de visar att ett företag kan sälja sina produkter eller tjänster för betydligt mer än produktionskostnaden. Rörelsemarginal beräknas genom att dividera företagets vinst med dess intäkter.